Effect of a local anaesthetic medication (lignocaine) in dose reduction of an intravenous anaesthetic agent used in obstructive sleep apnea patients undergoing sleep endoscopy procedure
Phase 4
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: J398- Other specified diseases of upperrespiratory tract
- Registration Number
- CTRI/2024/06/069478
- Lead Sponsor
- Department of Anaesthesia and Critical Care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients undergoing DISE procedure for mild, moderate or severe obstructive sleep apnea
Exclusion Criteria
Known or suspected allergy to studied drugs
Known or suspected allergy to studied drugs
Patients with gross mandibular or maxillary deformity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method